ReP USP - Resultado da busca

Artigo de periodico
SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4 (2019)
Wong, Deysi Viviana T.; Ribeiro Filho, Helder Veras; Wanderley, Carlos Wagner Souza; Leite, Caio Abner Vitorino Gonçalves; Lima, Jonilson Berlink; Assef, Alexia Nathália Brígido; Cajado, Aurilene Gomes; Batista, Gabriela Loiola Ponte; González, Rafael Holanda; Silva, Karla Oliveira; Borges, Luis Philipi Carvalho; Alencar, Nylane Maria Nunes de; Wilke, Diego Veras; Cunha, Thiago Mattar ; Figueira, Ana Carolina Migliorini; Cunha, Fernando de Queiroz ; Lima Júnior, Roberto César P.
Source: Cancer Chemotherapy and Pharmacology. Unidade: FMRP
Subjects: INFLAMAÇÃO, FÁRMACOS, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WONG, Deysi Viviana T. et al. SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4. Cancer Chemotherapy and Pharmacology, v. 84, n. 2, p. 287-298, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00280-019-03844-z. Acesso em: 06 nov. 2024.
APA
Wong, D. V. T., Ribeiro Filho, H. V., Wanderley, C. W. S., Leite, C. A. V. G., Lima, J. B., Assef, A. N. B., et al. (2019). SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4. Cancer Chemotherapy and Pharmacology, 84( 2), 287-298. doi:10.1007/s00280-019-03844-z
NLM
Wong DVT, Ribeiro Filho HV, Wanderley CWS, Leite CAVG, Lima JB, Assef ANB, Cajado AG, Batista GLP, González RH, Silva KO, Borges LPC, Alencar NMN de, Wilke DV, Cunha TM, Figueira ACM, Cunha F de Q, Lima Júnior RCP. SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4 [Internet]. Cancer Chemotherapy and Pharmacology. 2019 ; 84( 2): 287-298.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00280-019-03844-z
Vancouver
Wong DVT, Ribeiro Filho HV, Wanderley CWS, Leite CAVG, Lima JB, Assef ANB, Cajado AG, Batista GLP, González RH, Silva KO, Borges LPC, Alencar NMN de, Wilke DV, Cunha TM, Figueira ACM, Cunha F de Q, Lima Júnior RCP. SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4 [Internet]. Cancer Chemotherapy and Pharmacology. 2019 ; 84( 2): 287-298.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00280-019-03844-z
Artigo de periodico
NLRP12 attenuates inflammatory bone loss in experimental apical periodontitis (2019)
Taira, Thaise Mayumi ; Lima, V.; Prado, Douglas da Silva ; Silva, Taísa Alves ; Issa, João Paulo Mardegan ; Silva, Léa Assed Bezerra da ; Zamboni, Dario Simões ; Cunha, Fernando de Queiroz ; Fukada, Sandra Yasuyo
Source: Journal of Dental Research. Unidades: FORP, FMRP, FCFRP
Subjects: DOENÇAS PERIODONTAIS, PERIODONTITE PERIAPICAL, INFLAMAÇÃO, RECEPTORES, BIOMARCADORES, OSTEOCLASTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAIRA, Thaise Mayumi et al. NLRP12 attenuates inflammatory bone loss in experimental apical periodontitis. Journal of Dental Research, v. 98, n. 4, p. 476-484, 2019Tradução . . Disponível em: https://doi.org/10.1177/0022034518820289. Acesso em: 06 nov. 2024.
APA
Taira, T. M., Lima, V., Prado, D. da S., Silva, T. A., Issa, J. P. M., Silva, L. A. B. da, et al. (2019). NLRP12 attenuates inflammatory bone loss in experimental apical periodontitis. Journal of Dental Research, 98( 4), 476-484. doi:10.1177/0022034518820289
NLM
Taira TM, Lima V, Prado D da S, Silva TA, Issa JPM, Silva LAB da, Zamboni DS, Cunha F de Q, Fukada SY. NLRP12 attenuates inflammatory bone loss in experimental apical periodontitis [Internet]. Journal of Dental Research. 2019 ; 98( 4): 476-484.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1177/0022034518820289
Vancouver
Taira TM, Lima V, Prado D da S, Silva TA, Issa JPM, Silva LAB da, Zamboni DS, Cunha F de Q, Fukada SY. NLRP12 attenuates inflammatory bone loss in experimental apical periodontitis [Internet]. Journal of Dental Research. 2019 ; 98( 4): 476-484.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1177/0022034518820289
Artigo de periodico
TGFβ1 signaling sustains aryl hydrocarbon receptor (AHR) expression and restrains the pathogenic potential of TH17 cells by an AHR-independent mechanism (2018)
Lima, Kalil Alves de; Donate, Paula Barbim; Talbot, Jhimmy; Davoli-Ferreira, Marcela; Peres, Raphael Sanches; Cunha, Thiago Mattar; Alves Filho, José Carlos Farias; Cunha, Fernando de Queiroz
Source: Cell Death and Disease. Unidade: FMRP
Subjects: HIDROCARBONETOS, RECEPTORES, MARCADOR MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Kalil Alves de et al. TGFβ1 signaling sustains aryl hydrocarbon receptor (AHR) expression and restrains the pathogenic potential of TH17 cells by an AHR-independent mechanism. Cell Death and Disease, v. 9, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41419-018-1107-7. Acesso em: 06 nov. 2024.
APA
Lima, K. A. de, Donate, P. B., Talbot, J., Davoli-Ferreira, M., Peres, R. S., Cunha, T. M., et al. (2018). TGFβ1 signaling sustains aryl hydrocarbon receptor (AHR) expression and restrains the pathogenic potential of TH17 cells by an AHR-independent mechanism. Cell Death and Disease, 9. doi:10.1038/s41419-018-1107-7
NLM
Lima KA de, Donate PB, Talbot J, Davoli-Ferreira M, Peres RS, Cunha TM, Alves Filho JCF, Cunha F de Q. TGFβ1 signaling sustains aryl hydrocarbon receptor (AHR) expression and restrains the pathogenic potential of TH17 cells by an AHR-independent mechanism [Internet]. Cell Death and Disease. 2018 ; 9[citado 2024 nov. 06 ] Available from: https://doi.org/10.1038/s41419-018-1107-7
Vancouver
Lima KA de, Donate PB, Talbot J, Davoli-Ferreira M, Peres RS, Cunha TM, Alves Filho JCF, Cunha F de Q. TGFβ1 signaling sustains aryl hydrocarbon receptor (AHR) expression and restrains the pathogenic potential of TH17 cells by an AHR-independent mechanism [Internet]. Cell Death and Disease. 2018 ; 9[citado 2024 nov. 06 ] Available from: https://doi.org/10.1038/s41419-018-1107-7
Artigo de periodico
Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives (2016)
Ribeiro, Ronaldo A.; Wanderley, Carlos W. S.; Wong, Deysi V. T.; Mota, José Maurício S. C.; Leite, Caio A. V. G.; Souza, Marcellus H. L. P.; Cunha, Fernando de Queiroz; Lima Junior, Roberto César P.
Source: Cancer Chemotherapy and Pharmacology. Unidade: FMRP
Subjects: ENTEROPATIAS, ANTINEOPLÁSICOS, CITOCINAS, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Ronaldo A. et al. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives. Cancer Chemotherapy and Pharmacology, v. 78, n. 5, p. 881-893, 2016Tradução . . Disponível em: https://doi.org/10.1007/s00280-016-3139-y. Acesso em: 06 nov. 2024.
APA
Ribeiro, R. A., Wanderley, C. W. S., Wong, D. V. T., Mota, J. M. S. C., Leite, C. A. V. G., Souza, M. H. L. P., et al. (2016). Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives. Cancer Chemotherapy and Pharmacology, 78( 5), 881-893. doi:10.1007/s00280-016-3139-y
NLM
Ribeiro RA, Wanderley CWS, Wong DVT, Mota JMSC, Leite CAVG, Souza MHLP, Cunha F de Q, Lima Junior RCP. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives [Internet]. Cancer Chemotherapy and Pharmacology. 2016 ; 78( 5): 881-893.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00280-016-3139-y
Vancouver
Ribeiro RA, Wanderley CWS, Wong DVT, Mota JMSC, Leite CAVG, Souza MHLP, Cunha F de Q, Lima Junior RCP. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives [Internet]. Cancer Chemotherapy and Pharmacology. 2016 ; 78( 5): 881-893.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00280-016-3139-y
Artigo de periodico
Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain (2016)
Zarpelon, Ana C.; Rodrigues, Francielle C.; Lopes, Alexandre H.; Souza, Guilherme R.; Carvalho, Thacyana T.; Pinto, Larissa G.; Xu, Damo; Ferreira, Sérgio Henrique; Alves Filho, José Carlos Farias; McInnes, Iain B.; Ryffel, Bernhard; Quesniaux, Valérie F. J.; Reverchon, Flora; Mortaud, Stéphane; Menuet, Arnaud; Liew, Foo Y.; Cunha, Fernando de Queiroz; Cunha, Thiago Mattar; Verri Júnior, Waldiceu A.
Source: FASEB Journal. Unidade: FMRP
Subjects: INTERLEUCINAS, RECEPTORES, DOENÇAS DO SISTEMA NERVOSO, DOR, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZARPELON, Ana C. et al. Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain. FASEB Journal, v. 30, n. 1, p. 54-65, 2016Tradução . . Disponível em: https://doi.org/10.1096/fj.14-267146. Acesso em: 06 nov. 2024.
APA
Zarpelon, A. C., Rodrigues, F. C., Lopes, A. H., Souza, G. R., Carvalho, T. T., Pinto, L. G., et al. (2016). Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain. FASEB Journal, 30( 1), 54-65. doi:10.1096/fj.14-267146
NLM
Zarpelon AC, Rodrigues FC, Lopes AH, Souza GR, Carvalho TT, Pinto LG, Xu D, Ferreira SH, Alves Filho JCF, McInnes IB, Ryffel B, Quesniaux VFJ, Reverchon F, Mortaud S, Menuet A, Liew FY, Cunha F de Q, Cunha TM, Verri Júnior WA. Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain [Internet]. FASEB Journal. 2016 ; 30( 1): 54-65.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1096/fj.14-267146
Vancouver
Zarpelon AC, Rodrigues FC, Lopes AH, Souza GR, Carvalho TT, Pinto LG, Xu D, Ferreira SH, Alves Filho JCF, McInnes IB, Ryffel B, Quesniaux VFJ, Reverchon F, Mortaud S, Menuet A, Liew FY, Cunha F de Q, Cunha TM, Verri Júnior WA. Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain [Internet]. FASEB Journal. 2016 ; 30( 1): 54-65.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1096/fj.14-267146
Artigo de periodico
Granulocyte-colony stimulating factor (G-CSF)-induced mechanical hyperalgesia in mice: role for peripheral TNFα, IL-1β and IL-10 (2015)
Carvalho, Thacyana T.; Borghi, Sergio M.; Pinho-Ribeiro, Felipe A.; Mizokami, Sandra S.; Cunha, Thiago Mattar; Ferreira, Sérgio Henrique; Cunha, Fernando de Queiróz; Casagrande, Rúbia; Verri Júnior, Waldiceu Aparecido
Source: European Journal of Pharmacology. Unidade: FMRP
Subjects: INTERLEUCINAS, ANALGÉSICOS, RECEPTORES, MORFINA, LEUCÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Thacyana T. et al. Granulocyte-colony stimulating factor (G-CSF)-induced mechanical hyperalgesia in mice: role for peripheral TNFα, IL-1β and IL-10. European Journal of Pharmacology, v. 749, p. 62–72, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2014.12.023. Acesso em: 06 nov. 2024.
APA
Carvalho, T. T., Borghi, S. M., Pinho-Ribeiro, F. A., Mizokami, S. S., Cunha, T. M., Ferreira, S. H., et al. (2015). Granulocyte-colony stimulating factor (G-CSF)-induced mechanical hyperalgesia in mice: role for peripheral TNFα, IL-1β and IL-10. European Journal of Pharmacology, 749, 62–72. doi:10.1016/j.ejphar.2014.12.023
NLM
Carvalho TT, Borghi SM, Pinho-Ribeiro FA, Mizokami SS, Cunha TM, Ferreira SH, Cunha F de Q, Casagrande R, Verri Júnior WA. Granulocyte-colony stimulating factor (G-CSF)-induced mechanical hyperalgesia in mice: role for peripheral TNFα, IL-1β and IL-10 [Internet]. European Journal of Pharmacology. 2015 ; 749 62–72.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ejphar.2014.12.023
Vancouver
Carvalho TT, Borghi SM, Pinho-Ribeiro FA, Mizokami SS, Cunha TM, Ferreira SH, Cunha F de Q, Casagrande R, Verri Júnior WA. Granulocyte-colony stimulating factor (G-CSF)-induced mechanical hyperalgesia in mice: role for peripheral TNFα, IL-1β and IL-10 [Internet]. European Journal of Pharmacology. 2015 ; 749 62–72.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ejphar.2014.12.023
Trabalho de evento-resumo
NOD1 and NOD2 contribute to pain hypersensitivity and glial cells activation after induction of peripheral nerve injury (2015)
Santa-Cecília, Flávia; Santa-Cecília, F.; Ferreira, D. W.; Fonseca, M.; Cunha, Fernando de Queiroz; Zamboni, Dario Simões; Cunha, Thiago Mattar
Source: Abstracts. Conference titles: International Congress on Neuropathic Pain - NEUPSIG. Unidade: FMRP
Subjects: RECEPTORES, NERVOS PERIFÉRICOS (LESÕES)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTA-CECÍLIA, Flávia et al. NOD1 and NOD2 contribute to pain hypersensitivity and glial cells activation after induction of peripheral nerve injury. 2015, Anais.. Nice: IASP, 2015. . Acesso em: 06 nov. 2024.
APA
Santa-Cecília, F., Santa-Cecília, F., Ferreira, D. W., Fonseca, M., Cunha, F. de Q., Zamboni, D. S., & Cunha, T. M. (2015). NOD1 and NOD2 contribute to pain hypersensitivity and glial cells activation after induction of peripheral nerve injury. In Abstracts. Nice: IASP.
NLM
Santa-Cecília F, Santa-Cecília F, Ferreira DW, Fonseca M, Cunha F de Q, Zamboni DS, Cunha TM. NOD1 and NOD2 contribute to pain hypersensitivity and glial cells activation after induction of peripheral nerve injury. Abstracts. 2015 ;[citado 2024 nov. 06 ]
Vancouver
Santa-Cecília F, Santa-Cecília F, Ferreira DW, Fonseca M, Cunha F de Q, Zamboni DS, Cunha TM. NOD1 and NOD2 contribute to pain hypersensitivity and glial cells activation after induction of peripheral nerve injury. Abstracts. 2015 ;[citado 2024 nov. 06 ]
Artigo de periodico
Toll-like receptor 9 signaling in dendritic cells regulates neutrophil recruitment to inflammatory foci following Leishmania infantum infection (2015)
Sacramento, Laís Amorim; Trevelin, Silvia Cellone; Nascimento, Manuela Sales Lima; Lima Júnior, Djalma de Souza; Costa, Diego Luís; Almeida, Roque Pacheco de; Cunha, Fernando de Queiróz; Silva, João Santana da; Carregaro, Vanessa
Source: Infection and Immunity. Unidade: FMRP
Subjects: RECEPTORES, NEUTRÓFILOS, FÍGADO (PARASITOLOGIA), LEISHMANIOSE VISCERAL, REGULAÇÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SACRAMENTO, Laís Amorim et al. Toll-like receptor 9 signaling in dendritic cells regulates neutrophil recruitment to inflammatory foci following Leishmania infantum infection. Infection and Immunity, v. 83, n. 12, p. 4604–4616, 2015Tradução . . Disponível em: https://doi.org/10.1128/IAI.00975-15. Acesso em: 06 nov. 2024.
APA
Sacramento, L. A., Trevelin, S. C., Nascimento, M. S. L., Lima Júnior, D. de S., Costa, D. L., Almeida, R. P. de, et al. (2015). Toll-like receptor 9 signaling in dendritic cells regulates neutrophil recruitment to inflammatory foci following Leishmania infantum infection. Infection and Immunity, 83( 12), 4604–4616. doi:10.1128/IAI.00975-15
NLM
Sacramento LA, Trevelin SC, Nascimento MSL, Lima Júnior D de S, Costa DL, Almeida RP de, Cunha F de Q, Silva JS da, Carregaro V. Toll-like receptor 9 signaling in dendritic cells regulates neutrophil recruitment to inflammatory foci following Leishmania infantum infection [Internet]. Infection and Immunity. 2015 ; 83( 12): 4604–4616.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1128/IAI.00975-15
Vancouver
Sacramento LA, Trevelin SC, Nascimento MSL, Lima Júnior D de S, Costa DL, Almeida RP de, Cunha F de Q, Silva JS da, Carregaro V. Toll-like receptor 9 signaling in dendritic cells regulates neutrophil recruitment to inflammatory foci following Leishmania infantum infection [Internet]. Infection and Immunity. 2015 ; 83( 12): 4604–4616.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1128/IAI.00975-15
Trabalho de evento-resumo
The participation of AT1 receptor in the Ang II-increased contraction in the contralateral carotid artery after balloon catheter injury (2010)
Olivon, V. C.; Mestriner, F. L.; Cunha, Fernando de Queiroz; Oliveira, Ana Maria de
Source: Programa. Conference titles: Congresso Brasileiro de Farmacologia e Terapêutica Experimental. Unidades: FMRP, FCFRP
Subjects: ARTÉRIAS CARÓTIDAS, ANGIOPLASTIA COM BALÃO, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVON, V. C. et al. The participation of AT1 receptor in the Ang II-increased contraction in the contralateral carotid artery after balloon catheter injury. 2010, Anais.. Ribeirão Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2010. . Acesso em: 06 nov. 2024.
APA
Olivon, V. C., Mestriner, F. L., Cunha, F. de Q., & Oliveira, A. M. de. (2010). The participation of AT1 receptor in the Ang II-increased contraction in the contralateral carotid artery after balloon catheter injury. In Programa. Ribeirão Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Olivon VC, Mestriner FL, Cunha F de Q, Oliveira AM de. The participation of AT1 receptor in the Ang II-increased contraction in the contralateral carotid artery after balloon catheter injury. Programa. 2010 ;[citado 2024 nov. 06 ]
Vancouver
Olivon VC, Mestriner FL, Cunha F de Q, Oliveira AM de. The participation of AT1 receptor in the Ang II-increased contraction in the contralateral carotid artery after balloon catheter injury. Programa. 2010 ;[citado 2024 nov. 06 ]
Artigo de periodico
Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats (2008)
Barsante, M. M.; Cunha, T. M.; Allegretti, M.; Cattani, F.; Policani, F.; Bizzarri, C.; Tafuri, W. L.; Poole, S.; Cunha, Fernando de Queiroz; Bertini, R.; Teixeira, M. M.
Source: British Journal of Pharmacology. Unidade: FMRP
Subjects: ARTRITE REUMATOIDE, NEUTRÓFILOS, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARSANTE, M. M. et al. Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats. British Journal of Pharmacology, v. 153, n. 5, p. 992-1002, 2008Tradução . . Disponível em: https://doi.org/10.1038/sj.bjp.0707462. Acesso em: 06 nov. 2024.
APA
Barsante, M. M., Cunha, T. M., Allegretti, M., Cattani, F., Policani, F., Bizzarri, C., et al. (2008). Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats. British Journal of Pharmacology, 153( 5), 992-1002. doi:10.1038/sj.bjp.0707462
NLM
Barsante MM, Cunha TM, Allegretti M, Cattani F, Policani F, Bizzarri C, Tafuri WL, Poole S, Cunha F de Q, Bertini R, Teixeira MM. Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats [Internet]. British Journal of Pharmacology. 2008 ; 153( 5): 992-1002.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1038/sj.bjp.0707462
Vancouver
Barsante MM, Cunha TM, Allegretti M, Cattani F, Policani F, Bizzarri C, Tafuri WL, Poole S, Cunha F de Q, Bertini R, Teixeira MM. Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats [Internet]. British Journal of Pharmacology. 2008 ; 153( 5): 992-1002.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1038/sj.bjp.0707462

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation